Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
Histone deacetylase inhibitor and chemotherapy combined effect on Raji Burkitt's lymphoma cell line
PubMed Similar studies GEO Profiles Analyze DataSet
Histone Deacetylase Inhibitor prevents cell growth in Burkitt's lymphoma by regulating PI3K/Akt pathways and leading to up regulation of micro RNA-143, -145 and -101
PubMed Similar studies Analyze with GEO2R
Gene expression profile of the human leukemia cell line Reh after treatment with bortezomib, valproic acid or a combination of both.
miRNA expression of lymphoma cell lines with or without HDAC inhibitor treatment
PubMed Full text in PMC Similar studies Analyze with GEO2R
Small-RNA expression in normal and malignant mature B cells
PubMed Full text in PMC Similar studies SRA Run Selector
miR-28 expression in the Burkitt lymphoma cell line P3HR1
miR-28 expression effect on Burkitt lymphoma cell line: time course
PubMed Full text in PMC Similar studies GEO Profiles Analyze DataSet
Burkitt Lymphoma Pathogenesis and Therapeutic Targets from Structural and Functional Genomics
Synergy between PI3K Signaling and MYC in Burkitt Lymphomagenesis
miRNA expression in thyroid cancer cells
Effect of histone deacetylase inhibitors on miRNA expression in thyroid cancer cells
Overexpression of miR-129-5p in thyroid carcinoma cells
Deep sequencing of MYC DNA-binding sites in Burkitt's lymphoma
PubMed Full text in PMC Similar studies Analyze with GEO2RSRA Run Selector
circZDHHC11 knockdown in ST486 cells
Inhibition of the miR-155 target NIAM phenocopies the growth promoting effect of miR-155 in B-cell lymphoma
Inhibition of the miR-155 target NIAM phenocopies the growth promoting effect of miR-155 in B-cell lymphoma [KM-H2]
Inhibition of the miR-155 target NIAM phenocopies the growth promoting effect of miR-155 in B-cell lymphoma [L1236]
Inhibition of the miR-155 target NIAM phenocopies the growth promoting effect of miR-155 in B-cell lymphoma [ST486]
Microarray analysis to identify miRNA targetome of primary Burkitt lymphoma tumors in comparison to normal CD19+ B cells
Novel HDAC inhibitors exhibit pre-clinical efficacy in lymphoma models and point to the importance of CDKN1A expression levels in mediating their anti-tumor response
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on